TP53 and cancer: Rosenbaum et al. examined 96 strictures from 88 patients and reported that NGS exhibited higher sensitivity than cytology, whereas the presence of TP53, SMAD4, and CDKN2A mutations was 100% specific to detect HGD or cancer [90].